New data shows Alzheimer’s patients prefer long-term use of Leqembi with Eisai and Biogen’s insights
Recent findings from Eisai and Biogen reveal that a significant number of Alzheimer’s patients are opting to continue using Leqembi, indicating strong patient satisfaction and